(redirected from uremic)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.


(yo͝orē`mēə), condition resulting from advanced stages of kidney failure in which urea and other nitrogen-containing wastes are found in the blood. Uremia can be caused by NSAIDs (nonsteroid anti-inflammatory drugs), especially in older patients treated primarily with ibuprofenibuprofen
, nonsteroidal anti-inflammatory drug (NSAID) that reduces pain, fever, and inflammation. Along with naproxen and ketoprofen, ibuprofen belongs to the propionic acid class of NSAIDs. It was first made available in 1967.
..... Click the link for more information.
 for arthritis. Some of the early signs of uremia are lethargy, mental depression, loss of appetite, and edema; later symptoms include diarrhea, anemia, convulsions, coma, and a gray-brown coloration. Treatment of uremia, which is directed at the underlying kidney disease, is usually with dialysis and renal transplantation. Treatments with genetically engineered erythropoietin decrease the complication of anemia. See nephritisnephritis
, inflammation of the kidney. The earliest finding is within the renal capillaries (glomeruli); interstitial edema is typically followed by interstitial infiltration of lymphocytes, plasma cells, eosinophils, and a small number of polymorphonuclear leukocytes.
..... Click the link for more information.
; nephrosisnephrosis
, kidney disease characterized by lesions of the epithelial lining of the renal tubules, resulting in marked disturbance in the filtration function and the consequent appearance of large amounts of protein (albumin) in the urine (see urinary system).
..... Click the link for more information.



a toxic condition caused by severe impairment of renal function. It may be acute or chronic.

Acute uremia occurs in acute renal insufficiency during oliguria and is marked by severe impairment as well as by systemic disorders. The concentration of creatinine, urea, indican, ammonia, and other nitrogenous compounds increases markedly in the blood, resulting in azotemia. The content of such electrolytes as potassium, magnesium, calcium, and chlorine becomes altered, the acid-base balance is disturbed, resulting in acidosis, and water is retained in the body. Cardiovascular changes are manifested by tachycardia, arrhythmia, and hypertension. Other symtoms include anemia, digestive disorders, neurological disturbances, and often pulmonary edema. Acute uremia persists for five to ten days and sometimes up to 30 days or longer. The majority of persons affected with the disease return to work in three to 12 months.

Chronic uremia (terminal uremia, or terminal chronic renal insufficiency) is caused by many chronic kidney diseases. Affected persons experience lassitude, become emotionally unstable, and exhibit various types of neuromuscular phenomena. Hearing is impaired and the skin becomes pale yellow in color and is dry, flaccid, and painfully itchy. Other common symptoms are loss of appetite, nausea, vomiting, thirst, convulsions, polyneuritis, and nasal, cutaneous, or intestinal hemorrhages. The process of change in the electrolytes intensifies, and azotemia and acidosis become more marked. The bones decalcify and the joints are affected. Blood pressure rises sharply and pericarditis develops. The specific gravity of the urine remains low.

The treatment of uremia is conservative; methods used include cleansing of the blood by means of an artifical kidney or by peritoneal dialysis. A kidney transplant may be indicated.


Osnovy nefrologii, vol. 1. Edited by E. M. Tareev. Moscow, 1972. Pages 164–234.



A condition resulting from kidney failure and characterized by azotemia, chronic acidosis, anemia, and a variety of systemic signs and symptoms.
References in periodicals archive ?
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
Predictors of fatality in postdiarrheal hemolytic uremic syndrome.
Uremic toxins can induce apoptosis, with nephron-damaging and fibrosis-inviting "epithelial-to-mesenchymal transition" (EMT) in the proximal tubules.
Which of the following non-pharmacological strategies may be recommended for patients experiencing uremic pruritus?
Atkinson, "Complement regulatory genes and hemolytic uremic syndromes," Annual Review of Medicine, vol.
A potential diagnostic indicator is a calcium phosphate product over 70 mg/dL, as it has been shown that those with penile calcific uremic arteriolopathy had a significantly higher calcium phosphate product than a control group of patients with ESRD (p < 0.05) [7].
Recurrent ocular involvement in pediatric atypical hemolytic uremic syndrome.
Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
Factors that facilitate the prevention of stent thrombosis include suitable operation procedures, appropriate stent material and technique, and antiplatelet agents, which particularly play a major role in preventing stent thrombosis.[sup][4] However, uremic patients require long-term hemodialysis treatment, which may eliminate aspirin and clopidogrel from systemic circulation.
We report here a severely uremic patient with cerebral edema secondary to hemodialysis and the subsequent regression of cerebral edema.
Although urea transporters have now been identified in liver, heart, testis, and brain [9-12], little is known about its expression in sweat glands, especially in the sweat glands of uremic patients.
GlobalData's clinical trial report, "Uremic (Renal) Pruritus Global Clinical Trials Review, H1, 2016" provides an overview of Uremic (Renal) Pruritus clinical trials scenario.